An interdisciplinary palliative rehabilitation intervention bolstering general self-efficacy to attenuate symptoms of depression in patients living with advanced cancer

Supportive Care in Cancer

Volumn 24, Issue 1, 2016, Pages 109-117

  Feldstain, A ^a,b   Lebel, S ^a   Chasen, M R ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b BRUYÈRE RESEARCH INSTITUTE   (Canada)

Author keywords

Advanced cancer; Depression; Interdisciplinary; Palliative rehabilitation; Self efficacy

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ADVANCED CANCER; ARTICLE; CANCER PALLIATIVE THERAPY; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DEPRESSION; EXERCISE; FEMALE; GENERAL SELF EFFICACY SCALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; QUASI EXPERIMENTAL STUDY; REHABILITATION CARE; SELF CONCEPT; COMPLICATION; NEOPLASMS; PALLIATIVE THERAPY; QUALITY OF LIFE; SURVIVOR;

DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PALLIATIVE CARE; QUALITY OF LIFE; SELF EFFICACY; SURVIVORS;

EID: 84949085326     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-015-2751-4     Document Type: Article

References (49)

1. Institute of Medicine, National Research Council (2006) From cancer patient to cancer survivor: lost in transition. The National Academies Press, Washington
2. Chasen M, Jacobsen PB (2011) Rehabilitation in cancer. In: Olver IN (ed) The MASCC Textbook of Cancer Supportive Care and Survivorship. Springer, New York, pp 389–396
3. Hannon B, Swami N, Pope A, Rodin G, Dougherty E, Mak E, et al. (2014) The oncology palliative care clinic at the Princess Margaret Cancer Centre: an early intervention model for patients with advanced cancer. Support Care Cancer 23:1–8. doi: 10.1007/s00520-014-2460-4
4. Massie MJ, Lloyd-Williams M, Irving G, Miller K (2011) The prevalence of depression in people with cancer. In: Kissane DW, Maj M, Sartorius N (eds) Depression and Cancer. Wiley, UK, pp 1–36
5. Wilson KG, Lander M, Chochinov HM (2009) Diagnosis and management of depression in palliative care. In: Chochinov HM, Breitbart W (eds) Psychiatry in palliative care. Oxford University Press, New York, pp 39–68
6. Mayera A, Geiserb C, Infurnacd FJ, Fiegee C (2013) Modelling and predicting complex patterns of change using growth component models: an application to depression trajectories in cancer patients. Eur J Dev Psychol 10:40–59
7. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B (2007) Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 370:851–858
8. Al-Shahri MZ, Eldali AM, Al-Zahrani O (2012) Prevalence and severity of suffering among patients with advanced cancer. Support Care Cancer 20:3137–3140
9. Hotopf M, Chidgey J, Addington-Hall J, Ly KL (2002) Depression in advanced disease: a systematic review. Part 1. Prevalence and case finding. Palliat Med 16:81–97
10. Pinquart M, Duberstein PR (2010) Depression and cancer mortality: a meta-analysis. Psychol Med 40:1797–1810
11. Chasen M, Feldstain A, Gravelle D, MacDonald N, Pereira J (2013) An interprofessional palliative care oncology rehabilitation program: effects on function and predictors of program completion. Curr Oncol 20:301–309
12. Chasen MR, Dippenaar AP (2008) Cancer nutrition and rehabilitation—its time has come! Curr Oncol 15:2–6
13. Feldstain A, Lebel S, Chasen M (2014) Longitudinal depression scores for patients who have undergone a palliative rehabilitation program (conference proceedings). Support Care Cancer 22(Suppl 1):172
14. Deans C, Wigmore SJ (2005) Systemic inflammation, cachexia and prognosis in patients with cancer. Curr Opin Clin Nutr Metab Care 8:265–269
15. Mahmoud F, Rivera N (2002) The role of C-reactive protein as a prognostic indicator in advanced cancer. Curr Oncol Rep 4:250–255
16. MacDonald N (2011) Chronic inflammatory states: their relationship to cancer prognosis and symptoms. J R Coll Physicians Edinb 41:246–253
17. Miller AH, Raison CL (2008) Immune system contributions to the pathophysiology of depression. Focus: J Lifelong Learn 6:36–45
18. MacDonald N (2007) Cancer cachexia and targeting chronic inflammation: a unified approach to cancer treatment and palliative/supportive care. J Support Oncol 5:157–162
19. Brown JC, Huedo-Medina TB, Pescatello LS, Ryan SM, Pescatello SM, Moker E et al (2012) The efficacy of exercise in reducing depressive symptoms among cancer survivors: a meta-analysis. PLoS ONE 7, e30955
20. Mishra SI, Scherer RW, Geigle PM, Berlanstein DR, Topaloglu O, Gotay CC, Snyder C (2012) Exercise interventions on health-related quality of life for cancer survivors. Cochrane Database Syst Rev 8, CD007566. doi:10.1002/14651858.CD007566.pub2
21. Craft LL, VanIterson EH, Helenowski IB, Rademaker AW, Courneya KS (2011) Exercise effects on depressive symptoms in cancer survivors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 21:3–19
22. Mead GE, Morley W, Campbell P, Greig CA, McMurdo M, Lawlor DA (2009) Exercise for depression. Cochrane Database Syst Rev 8:CD004366. doi: 10.1002/14651858.CD004366.pub4
23. Bandura A (1977) Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev 84:191–215
24. Luszczynska A, Scholz U, Schwarzer R (2005) The General Self-Efficacy Scale: multicultural validation studies. J Psychol 139:439–457
25. Luszczynska A, Gutiérrez-Dona B, Schwarzer R (2005) General self-efficacy in various domains of human functioning: evidence from five countries. Int J Psychol 40:80–89
26. Bandura A (1998) Health promotion from the perspective of social cognitive theory. Psychol Health 13:623–649
27. Bandura A, O’Leary A, Taylor CB, Gauthier J, Gossard D (1987) Perceived self-efficacy and pain control: opioid and nonopioid mechanisms. JPSP 53:563–571
28. Kohno Y, Maruyama M, Matsuoka Y, Matsushita T, Koeda M, Matsushima E (2010) Relationship of psychological characteristics and self-efficacy in gastrointestinal cancer survivors. Psychooncology 19:71–76
29. Cheung WY, Le LW, Gagliese L, Zimmerman C (2011) Age and gender differences in symptom intensity and symptom clusters among patients with metastatic cancer. Support Care Cancer 19:417–423
30. Parker PA, Baile WF, de Moor C, Cohen L (2002) Psychosocial and demographic predictors of quality of life in a large sample of cancer patients. Psychooncology 12:183–193
31. Korhonen T, Bromh U, Varjonen J, Romanov K, Koskenvuo M, Kinnunen T, Kaprio J (2007) Smoking behaviour as a predictor of depression among Finnish men and women: a prospective cohort study of adult twins. Psychol Med 37:705–715
32. Delgadillo J, Godfrey C, Gilbody S, Payne S (2013) Depression, anxiety and comorbid substance use: association patterns in outpatient addictions treatment. Ment Health Subst Use 6:59–75
33. Simmonds MJ (2002) Physical function in patients with cancer: psychometric characteristics and clinical usefulness of a physical performance test battery. J Pain Symptom Manag 24:404–414
34. Society AT (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111–117
35. Enright PL, McBurnie MA, Bittner V, Tracy RP, McNamara R, Arnold A, Newman AB (2003) The 6-min walk test: a quick measure of functional status in elderly adults. Chest 123:387–398
36. Schwarzer R, Jerusalem M (1995) Generalized self-efficacy scale. In: Weinman J, Wright S, Johnston M (eds) Measures in health psychology: a user’s portfolio causal and control beliefs. NFER-NELON, Windsor, pp 35–37
37. Brady TJ (2003) Measures of self-efficacy, helplessness, mastery, and control: The Arthritis Helplessness Index (AHI)/Rheumatology Attitudes Index (RAI), Arthritis Self-Efficacy Scale (ASES), Children’s Arthritis Self-Efficacy Scale (CASE), Generalized Self-Efficacy Scale (GSES), Mastery Scale, Multi-Dimensional Health Locus of Control Scale (MHLC), Parent’s Arthritis Self-Efficacy Scale (PASE), Rheumatoid Arthritis Self-Efficacy Scale (RASE), and Self-Efficacy Scale (SES). Arthritis Rheum 49:S147–S164
38. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370
39. Luckett T, Butow P, King M, Oguchi M, Heading G, Hackl N, Rankin N, Price M (2010) A review and recommendations for optimal outcome measures of anxiety, depression and general distress in studies evaluating psychosocial interventions for English-speaking adults with heterogeneous cancer diagnoses. Support Care Cancer 18:1241–1262
40. Vodermaier A, Linden W, Siu C (2009) Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst 101:1464–1488
41. Dalecki M, Willits FK (1991) Examining change using regression analysis: three approaches compared. Sociol Spectr 11:127–145
42. Gillespie DF, Streeter CL (1994) Fitting regression models to research questions for analyzing change in nonexperimental. Soc Work Res 18:239–245
43. Faul F, Erdfelder E, Lang AG, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175–191
44. Sinharay S, Stern HS, Russell D (2001) The use of multiple imputation for the analysis of missing data. Psychol Methods 6:317–329
45. Sorensen JB, Klee M, Palshof T, Hansen HH (1993) Performance status assessment in cancer patients. An inter-observer variability study. Br J Cancer 67:773–775
46. Josefsson T, Lindwall M, Archer T (2014) Physical exercise intervention in depressive disorders: meta-analysis and systematic review. Scan J Med Sci Sports 24:259–272
47. Sturmey P (2009) Behavioral activation is an evidence-based treatment for depression. Behav Modif 33:818–829
48. Rhondali W, Yennurajalingam S, Ferrer J, Chisholm G, Filbet M, Bruera E (2013) Association between supportive care interventions and patient self-reported depression among advanced cancer outpatients. Psychooncology 22:987–994
49. Yost KJ, Eton DT, Garcia SF, Cella D (2011) Minimally important differences were estimated for six PROMIS-Cancer scales in advanced stage cancer patients. J Clin Epidemiol 64:507–516